We collaborate with partners worldwide to engage others in industry, academia, leaders, and civil society in this critical dialogue.
Innovation that reflects women’s unique biology can unlock breakthroughs across conditions that have long been overlooked and misunderstood.

Pervasive conditions affecting women—including endometriosis, uterine fibroids, PCOS, menopausal symptoms, breast and ovarian cancer, and pregnancy and fertility-related complications—have been chronically underserved by innovation. Despite living an average of five years longer than men, women spend 25% more of their lives in poor health or with disability. New insights into female-specific immunology, neuroendocrine regulation, and metabolism are revealing untapped therapeutic opportunities. Breakthroughs in this area could redefine care for conditions affecting hundreds of millions worldwide.
What if effective treatments could relieve the pain of endometriosis and PCOS or risks associated with pregnancy, and the complications of menopause, restoring years of productivity and wellbeing?